These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Intradermal or Sublingual Delivery and Heat-Labile Enterotoxin Proteins Shape Immunologic Responses to a CFA/I Fimbria-Derived Subunit Antigen Vaccine against Enterotoxigenic Escherichia coli. Maciel M; Bauer D; Baudier RL; Bitoun J; Clements JD; Poole ST; Smith MA; Kaminski RW; Savarino SJ; Norton EB Infect Immun; 2019 Nov; 87(11):. PubMed ID: 31427449 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant effect of enterotoxigenic Seo H; Lu T; Mani S; Bourgeois AL; Walker R; Sack DA; Zhang W Hum Vaccin Immunother; 2020; 16(2):419-425. PubMed ID: 31361177 [TBL] [Abstract][Full Text] [Related]
4. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant. Holmgren J; Bourgeois L; Carlin N; Clements J; Gustafsson B; Lundgren A; Nygren E; Tobias J; Walker R; Svennerholm AM Vaccine; 2013 May; 31(20):2457-64. PubMed ID: 23541621 [TBL] [Abstract][Full Text] [Related]
6. Genetic fusions of a CFA/I/II/IV MEFA (multiepitope fusion antigen) and a toxoid fusion of heat-stable toxin (STa) and heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC) retain broad anti-CFA and antitoxin antigenicity. Ruan X; Sack DA; Zhang W PLoS One; 2015; 10(3):e0121623. PubMed ID: 25803825 [TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study. Lundgren A; Bourgeois L; Carlin N; Clements J; Gustafsson B; Hartford M; Holmgren J; Petzold M; Walker R; Svennerholm AM Vaccine; 2014 Dec; 32(52):7077-84. PubMed ID: 25444830 [TBL] [Abstract][Full Text] [Related]
9. Preclinical Characterization of Immunogenicity and Efficacy against Diarrhea from MecVax, a Multivalent Enterotoxigenic E. coli Vaccine Candidate. Seo H; Garcia C; Ruan X; Duan Q; Sack DA; Zhang W Infect Immun; 2021 Jun; 89(7):e0010621. PubMed ID: 33875477 [TBL] [Abstract][Full Text] [Related]
10. Antibody induction in mice by liposome-displayed recombinant enterotoxigenic Escherichia coli (ETEC) colonization antigens. Zhou S; Yu KOA; Mabrouk MT; Jahagirdar D; Huang WC; Guerra JA; He X; Ortega J; Poole ST; Hall ER; Gomez-Duarte OG; Maciel M; Lovell JF Biomed J; 2023 Dec; 46(6):100588. PubMed ID: 36925108 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/L211A) by intradermal immunization in mice. Maciel M; Smith M; Poole ST; Laird RM; Rollenhagen JE; Kaminski RW; Wenzel H; Bourgeois AL; Savarino SJ PLoS One; 2019; 14(11):e0224073. PubMed ID: 31682624 [TBL] [Abstract][Full Text] [Related]
12. Attenuated Escherichia coli strains expressing the colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin (LThK63) enhance clearance of ETEC from the lungs of mice and protect mice from intestinal ETEC colonization and LT-induced fluid accumulation. Byrd W; Boedeker EC Vet Immunol Immunopathol; 2013 Mar; 152(1-2):57-67. PubMed ID: 23122616 [TBL] [Abstract][Full Text] [Related]
13. Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein. Lundgren A; Leach S; Tobias J; Carlin N; Gustafsson B; Jertborn M; Bourgeois L; Walker R; Holmgren J; Svennerholm AM Vaccine; 2013 Feb; 31(8):1163-70. PubMed ID: 23306362 [TBL] [Abstract][Full Text] [Related]
14. U-Omp19 from Brucella abortus increases dmLT immunogenicity and improves protection against Escherichia coli heat-labile toxin (LT) oral challenge. Coria LM; Martinez FL; Bruno LA; Pasquevich KA; Cassataro J Vaccine; 2020 Jul; 38(32):5027-5035. PubMed ID: 32536545 [TBL] [Abstract][Full Text] [Related]
15. From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development. Svennerholm AM Indian J Med Res; 2011 Feb; 133(2):188-96. PubMed ID: 21415493 [TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of a prototype enterotoxigenic Escherichia coli adhesin vaccine in mice and nonhuman primates. Sincock SA; Hall ER; Woods CM; O'Dowd A; Poole ST; McVeigh AL; Nunez G; Espinoza N; Miller M; Savarino SJ Vaccine; 2016 Jan; 34(2):284-291. PubMed ID: 26597148 [TBL] [Abstract][Full Text] [Related]